Donaco International Limited (DNA.AX)
ValueMarkers Composite Index
77% below intrinsic value ($0)
Donaco International Limited (DNA.AX) — VMCI valuation read
DNA.AX screens at VMCI 64/100, a 14-point gap above the Consumer Cyclical sector median (50). For a mid-cap Donaco International Limited share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.
DNA.AX has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.
**Investor frame.** Value: DNA.AX trades at 18.0x earnings, 0% above the Consumer Cyclical median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Consumer Cyclical group. Quality: ROIC of 16.0% sits 6.0pp above the Consumer Cyclical median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -2.3x leaves covenant headroom, which sets the rate-cycle exposure for Donaco International Limited.
DNA.AX rose 1.9% over the trailing 7 days, with a -7.0% read on a 30-day basis.
Donaco International Limited engages in the leisure and entertainment business in the Asia Pacific region. It operates Star Vegas Resort & Club, a casino and hotel complex that comprises approximately 100 gaming tables, 800 slot machines, and 385 hotel rooms in Poipet, Cambodia; and Aristo International Hotel, a boutique casino, which includes 400 hotel rooms in northern Vietnam located in Yunnan, China. The company was incorporated in 1990 and is based in Sydney, Australia.
Related Stocks in Consumer Cyclical
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.